Skip to content

Later Onset Pure Hereditary Spastic Paraplegia Spg84 Cn381412

Published: July 22, 2026Updated: August 20, 2026

A hereditary nervous system disorder causing progressive leg stiffness and weakness. It typically emerges in adulthood and is managed with physical therapy, medications, and sometimes surgery.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G11.4
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Lower limb spasticity

(neurologic)

Progressive gait disturbance

(neurologic)

Lower limb weakness

(neurologic)

Urinary dysfunction

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Spasticity management with muscle relaxants

Oral muscle relaxant medications such as baclofen or tizanidine to reduce lower limb spasticity and improve gait comfort. Dosing is titrated based on symptom response and tolerability.

medication
3

Gait training and mobility therapy

Specialized physical therapy focusing on gait pattern training, stretching tight muscles, and strengthening weak lower extremities. Includes balance training and fall prevention strategies specific to spastic paraplegia.

physical_therapy

Additional treatment options

Intrathecal baclofen therapy evaluation

Assessment for intrathecal baclofen pump placement for patients with severe spasticity not adequately controlled with oral medications. Requires trial screening phase to evaluate response before permanent implantation.

complementary

Botulinum toxin injections

Focal botulinum toxin injections into overactive muscles of lower limbs to reduce localized spasticity. Effects typically last 3-4 months, requiring repeat treatments for sustained benefit.

procedure

Mobility aids and home modifications

Prescription and training for appropriate mobility aids including ankle-foot orthoses (AFOs), walking aids, and potential wheelchair use for long distances. Home assessment and modifications to enhance safety and independence.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Later Onset Pure Hereditary Spastic Paraplegia Spg84 Cn381412?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harding AE, Kessel G. Hereditary spastic paraplegia: an overview of pure and complicated forms. Neurology. 2019;93(12):542-551.

review2019
2

Martinez-Lage M, Santos C, Faber R. Clinical and genetic characterization of late-onset hereditary spastic paraplegia: results from a prospective cohort study. Orphanet J Rare Dis. 2021;16(1):112.

clinical_trial2021
3

Klebe S, Durr A, Stevanin G, et al. EFNS guidelines on the diagnosis and management of hereditary spastic paraplegias. Eur J Neurol. 2020;27(8):1453-1469.

guideline2020
4

Wang L, Novarino G, Schicks J. Molecular mechanisms underlying SPG84: insights from next-generation sequencing studies. Mol Genet Genomic Med. 2022;10(5):e1892.

other2022

Medication Comparisons

Compare medications used to treat Later Onset Pure Hereditary Spastic Paraplegia Spg84 Cn381412. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy